Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00831961 · ClinicalTrials.gov registry record

Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics

A clinical trial of Age-related Macular Degeneration, sponsored by Vanderbilt University.

Completed
Registry status
24
Enrollment target
1
Study location

NCT00831961: Completed study of Age-related Macular Degeneration, sponsored by Vanderbilt University.

NCT00831961 is a study of Age-related Macular Degeneration that has completed, run by Vanderbilt University. The registered enrollment target is 24 participants, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00831961, a study of Age-related Macular Degeneration, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

Repeated exposure to topical antibiotics may alter the normal bacteria on the eye and in the nose and increase rates of resistance. This study will determine whether repeated short-term exposure to topical antibiotic drops which are commonly prescribed after eye injections to reduce the chance of infection increase rates of resistant bacteria which are normally found on the eye and in the nose. We hypothesis that certain commercially available antibiotics may increase rates of bacteria resistance more so than others.

Interventions

  • PROCEDURE Conjunctival and nasopharyngeal bacteria cultures

Study Locations (1)

Tennessee

  • Vanderbilt Eye Institute - Nashville

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2009-01
Vanderbilt University

430 total trials

What the finished NCT00831961 record still lists

NCT00831961 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which Conjunctival and nasopharyngeal bacteria cultures is the first listed.

NCT00831961 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT00831961 about?

NCT00831961 is a clinical study titled "Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics". Repeated exposure to topical antibiotics may alter the normal bacteria on the eye and in the nose and increase rates of resistance. This study will determine whether repeated short-term exposure to topical antibiotic drops which are commonly prescribed after eye injections to reduce the chance of in...

What is the current status of trial NCT00831961?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2009-01.

What conditions does trial NCT00831961 study?

This clinical trial studies the following conditions: Age-related Macular Degeneration.

What interventions are being tested in trial NCT00831961?

The interventions under investigation include: Conjunctival and nasopharyngeal bacteria cultures (PROCEDURE).

Who is sponsoring clinical trial NCT00831961?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00831961 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Age-related Macular Degeneration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00831961's enrollment target sits among peer trials

24 64th of 74 higher than 10 of 74 other Age-related Macular Degeneration trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Age-related Macular Degeneration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00831961, the US trial registry maintained by the National Library of Medicine. NCT00831961 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.